UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 455

Sortiert nach

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients

Scientific reports, 2021-01, Vol.11 (1), p.2313-2313, Article 2313

2021

Link zum Volltext

Verfügbarkeit prüfen

Response to A. Chauhan and A. Pal

British journal of cancer, 2022-06, Vol.126 (11), p.1661-1662

2022

Link zum Volltext

Verfügbarkeit prüfen

ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

Clinical cancer research, 2018-03, Vol.24 (6), p.1500-1510

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer

World journal of gastroenterology : WJG, 2014-06, Vol.20 (22), p.6809-6814

2014

Link zum Volltext

Verfügbarkeit prüfen

Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR

Cancers, 2021-06, Vol.13 (11), p.2736

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR

Clinical chemistry (Baltimore, Md.), 2008-10, Vol.54 (10), p.1696-1704

2008

Link zum Volltext

Verfügbarkeit prüfen

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Nature genetics, 2014-05, Vol.46 (5), p.438-443

2014

Link zum Volltext

Verfügbarkeit prüfen

Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer

British journal of cancer, 2022-06, Vol.126 (11), p.1563-1569

2022

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer

Scientific reports, 2023-01, Vol.13 (1), p.1258-1258, Article 1258

2023

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Molecular oncology, 2019-12, Vol.13 (12), p.2515-2530

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)

Cellular physiology and biochemistry, 2016-01, Vol.40 (3-4), p.411-419

2016

Link zum Volltext

Verfügbarkeit prüfen

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer

Molecular oncology, 2021-09, Vol.15 (9), p.2412-2422

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758834017750121-1758834017750121

2018

Link zum Volltext

Verfügbarkeit prüfen

Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway

BMC cancer, 2015-07, Vol.15 (1), p.542-542, Article 542

2015

Link zum Volltext

Verfügbarkeit prüfen

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2177-2184

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

International journal of molecular sciences, 2021-01, Vol.22 (2), p.925

2021

Link zum Volltext

Verfügbarkeit prüfen

DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment

Cancers, 2021-11, Vol.13 (23), p.5974

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of TWIST1 , CD24 , CD44 , and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients

Cells (Basel, Switzerland), 2019-06, Vol.8 (7), p.652

2019

Link zum Volltext

Verfügbarkeit prüfen

A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients

Journal of Immunology Research, 2014-01, Vol.2014, p.659294-12

2014

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer

Cell reports (Cambridge), 2016-06, Vol.16 (1), p.120-132

2016

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization

Breast cancer research : BCR, 2019-08, Vol.21 (1), p.86-86, Article 86

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

PloS one, 2015-06, Vol.10 (6), p.e0123683-e0123683

2015

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer

PloS one, 2017-07, Vol.12 (7), p.e0181211-e0181211

2017

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact

Cancers, 2023-03, Vol.15 (7), p.1974

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 455

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(439)
Mit Volltextzugriff
(418)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(324)
Life Sciences & Biomedicine
(310)
Humans
(280)
Oncology
(253)
Female
(202)
Aged
(171)
Middle Aged
(166)
Adult
(136)
Biological And Medical Sciences
(129)
Male
(129)
Medical Sciences
(124)
Tumors
(95)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(82)
Lung Neoplasms - Drug Therapy
(78)
Chemotherapy
(74)
Breast Cancer
(71)
Treatment Outcome
(62)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(61)
Aged, 80 And Over
(60)
Prognosis
(58)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(47)
Cancer Research
(37)
Lung Cancer
(27)
Cancer Chemotherapy And Pharmacology
(19)
Anticancer Research
(18)
Clinical Lung Cancer
(13)
Oncology
(13)
Cancers
(12)
Plos One
(11)
Breast Cancer Research : Bcr
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients

Response to A. Chauhan and A. Pal

ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment

Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR

Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer

Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer

Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment

Prognostic Significance of TWIST1 , CD24 , CD44 , and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients

A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients

Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer

The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact

Suchergebnisse filtern